InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,565.75
(
-0.03%
)
US TECH 100
19,851.92
(
0.03%
)
Dow Jones
39,305.12
(
-0.18%
)
Brent Oil
85.49
(
-1.17%
)
Bitcoin
55,668.13
(
-0.32%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

$heff

Send PM Follow Ignore
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

$heff

Re: $heff post# 56894

Wednesday, 07/25/2012 12:21:42 PM

Wednesday, July 25, 2012 12:21:42 PM

Post# of 97239
TLON..$1.64 The ONXX approval of Carfolzomib was huge IMO. Their approval was one week early. Those were the only two drugs (Carfolzomib & Marqibo) all year with Accelerated Approval (standard review) in 2012. Carfilzomib was approved on July 20th. A few others had priority review. Both had positive ADCOM Mtngs. The company is in label negotiations with the FDA. An analyst, gregory Wade, with Wedbush Securities thinks that is a very positive thing. http://bloom.bg/IDzv8m

This stock seems to be getting moved by big money like Warburg Pincus. They have 3 seats on the board of directors of Talon. What is big money? http://bit.ly/xkOh0d
http://www.warburgpincus.com/portfolio/ViewCompany,id,480.aspx
http://www.warburgpincus.com/portfolio/Default.aspx

Sheff's Station...All Aboard...Sign Up Here!

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up